Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chemical Separation . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114181056A discloses Cage Arene CA-1 for energy-efficient benzene and cyclohexane separation via programmed release adsorption technology.
Patent CN101307040B details a novel NBS derivatization method for separating Paclitaxel from Cephalomannine, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101307040B details a novel NBS addition method for separating Paclitaxel from Cephalomannine, offering significant cost reduction in API manufacturing and high purity.
Patent CN102020619B reveals a mild 1,4-addition method for separating Cephalomannine from Taxol, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Advanced enzymatic and chemical separation process for high-purity escitalopram intermediates. Reduces manufacturing costs and improves supply chain reliability for global API producers.
Novel separation method for trans-1-2-cyclohexanediamine via patent CN117417259A. Enhances purity and supply chain efficiency for pharmaceutical intermediate manufacturing.
Patent CN101838282B details a cost-effective resolution method for 4-AA, avoiding expensive catalysts for reliable pharmaceutical intermediate supply.